Surgeons will need to tackle three major challenges with the most potential to reduce major causes of death and improve access to surgical care, according to an international group of experts.
Governments around the world must do more to tackle the growing threat of drug-resistant infections, new research led by the University of Leeds suggests.
Preterm birth affects nearly 10% of pregnancies worldwide, and rates are on the rise. A new approach that analyzes electrical activity during pregnancy, could improve predictions.
Gene alterations in biliary tract cancer offer potential targets for current or future precision therapies. This is demonstrated by a new study from Vienna.
People with strong legs are less likely to develop heart failure after a heart attack, according to research presented at the Heart Failure 2023 scientific congress in Prague.
German researchers have now investigated whether there is a temporal association between infection with the Sars-CoV-2 virus and the development of type 1 diabetes.
A University of Arizona Health Sciences-led study found that more than 50% of people don't fully trust AI-powered medical advice, but many put faith in AI if it's monitored and guided by human touch.
New research from the University of Helsinki increases the understanding of ovarian cancer: the identification of new subtypes could help discover new treatments.
A team at the Finnish research institute VTT has created a biodegradable ECG patch, aiming to pave the way to a more sustainable future for wearable electronic devices.
The latest version of ChatGPT passed a radiology board-style exam, highlighting the potential of large language models (LLM) but also revealing limitations that hinder reliability, new research shows.
Researchers from the Organoid group (Hubrecht Institute) and UMC Utrecht have developed a biobank with organoids derived from patients with head and neck cancer (HNC).
Japanese researchers have found that natural language processing might be an effective tool to analyze specific speech changes of patients with Parkinson's disease, allowing for better diagnosis.
An algorithm developed using artificial intelligence could soon be used by doctors to diagnose heart attacks with better speed and accuracy than ever before, according to new research.
An artificial intelligence developed at TU Wien (Vienna) can suggest appropriate treatment steps in cases of blood poisoning. The computer has already surpassed humans in this respect.
Tumors sometimes seem to take on a life of their own, with cancer genes “striking out” in ring shapes. An international research team has new insights into this phenomenon.
For decades, hearing aids have been focused on improving communication. While the technology has made strides in terms of speech, it is still subpar when it comes to music.
Researchers at the University of Helsinki have demonstrated that certain strains of Desulfovibrio bacteria are the likely cause of Parkinson’s disease in most cases.
Newly developed “smart” coatings for surgical orthopedic implants can monitor strain on the devices to provide early warning of implant failures while killing infection-causing bacteria.
Artificial Intelligence (AI) could identify patients at increased risk of side effects from radiation treatment for breast cancer, according to researchers at the University of Leicester.
Dutch scientists have revealed new scientific insights into the features of fibrolamellar carcinoma (FLC), a rare type of childhood liver cancer.
Researchers have succeeded in introducing a vascular system into tiny living and beating model human heart muscles, an achievement which it's hoped will accelerate progress toward the ultimate goal of repairing damage from heart disease.
Clinicians in an intensive care unit need to make complex decisions quickly and precisely, monitoring critically ill or unstable patients around the clock.
A group of researchers has illustrated the mechanistic pathway for PTEN-deficient breast cancer and successfully tested a method of countering the downstream effects of immune system evasion by tumors.
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.
Scientists at the University of Applied Sciences Krems (IMC Krems) show that CRISPR-Cas9 can also be used to inhibit viruses such as adenoviruses in cell cultures.
